# Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation

Study · id `cardio:ct-nct02565693` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02565693](<https://clinicaltrials.gov/study/NCT02565693>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02565693

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

## Technical summary

Registry record NCT02565693. Randomized; single masking; primary purpose treatment. Start 2014-09 (actual); primary completion 2021-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 101 participants (enrolled count; ClinicalTrials.gov record NCT02565693, source copy `cardio:ctgov-nct02565693-2021-04-14`, retrieved 2026-10-26)
- Started: 2014-09 (actual) (ClinicalTrials.gov record NCT02565693, source copy `cardio:ctgov-nct02565693-2021-04-14`, retrieved 2026-10-26)
- Primary completion: 2021-01-31 (actual) (ClinicalTrials.gov record NCT02565693, source copy `cardio:ctgov-nct02565693-2021-04-14`, retrieved 2026-10-26)
- Completion: 2021-01-31 (actual) (ClinicalTrials.gov record NCT02565693, source copy `cardio:ctgov-nct02565693-2021-04-14`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT02565693, source copy `cardio:ctgov-nct02565693-2021-04-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02565693-2021-04-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
- Acronym: APACHE-AF
- Condition: Cerebral Hemorrhage
- Condition: Atrial Fibrillation
- Intervention (Drug): Apixaban
- Intervention (Drug): Aspirin
- Intervention (Drug): Carbasalate calcium
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Dipyridamole
- Intervention (Other): No antithrombotic treatment
- Lead sponsor: UMC Utrecht
- Lead sponsor class: OTHER
- Collaborator: Dutch Heart Foundation
- Collaborator class: OTHER
- Collaborator: ZonMw: The Netherlands Organisation for Health Research and Development
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry intervention name matches this record: Apixaban (`cardio:apixaban`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: UMC Utrecht (`cardio:org-umc-utrecht`)
- Registry lists this organization as a collaborator: Hartstichting (`cardio:org-hartstichting`)
- Registry lists this organization as a collaborator: ZonMw: The Netherlands Organisation for Health Research and Development (`cardio:org-zonmw-the-netherlands-organisation-for-health-research-and-cc2e75`)

## Provenance

Content hash: 6270f1c994093a546ed84b51960aebec2d69ac1103c05853021ed4d949e80d07
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
